Capoy, Gresila B.
HRN: 26-59-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2025
CEFTRIAXONE 1G (VIAL)
03/13/2025
03/19/2025
IV
1gram
Q12
Sacral Ulcer Grade 3
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes